Cancer mutation gains ground as test for immunotherapy drugs – Reuters
Reuters |
Cancer mutation gains ground as test for immunotherapy drugs
Reuters MADRID (Reuters) – Scientists are stepping up the hunt for better diagnostic tests to predict if cancer patients will benefit from costly modern immunotherapy drugs, which are transforming cancer care but remain a hit-and-miss affair. Research … Roche blood test could help 'personalize' cancer immunotherapy ESMO17: Foundation biomarker test could help boost immunotherapy Roche hopes blood test will predict immunotherapy efficacy |
